Onkologie. 2012:6(6):304-308
The frequency of invasive fungal infections has significantly increased with the rise in at-risk populations of patients in the last years. Management
of deep fungal infection is difficult and the morbidity and mortality of these infections are very high. New antifungal agents provide the
managment options and improve therapeutic outcomes of these infections. This article informs about the role of available antifungal agents
in the management of invasive fungal infections and reviews empirical antifungal treatmnet and the treatment of invasive aspergillus and
candida infections. Recommendations presented below are based on the resume of the Europen Conference on Infection in Leukemia (ECIL).
Published: December 1, 2012 Show citation